A5000445339- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- COVID-19 and healthcare impacts
- Cardiac Valve Diseases and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- COVID-19 Clinical Research Studies
- Venous Thromboembolism Diagnosis and Management
- Peripheral Artery Disease Management
- Cardiovascular Disease and Adiposity
- Heparin-Induced Thrombocytopenia and Thrombosis
- Mechanical Circulatory Support Devices
- Cerebrovascular and Carotid Artery Diseases
- Infective Endocarditis Diagnosis and Management
- Pericarditis and Cardiac Tamponade
- Cardiac Arrhythmias and Treatments
- Cardiac Arrest and Resuscitation
- Vascular Procedures and Complications
- Atrial Fibrillation Management and Outcomes
- Healthcare cost, quality, practices
- Aortic Disease and Treatment Approaches
- Cardiac tumors and thrombi
- Cardiac pacing and defibrillation studies
- Cardiovascular Health and Risk Factors
North Shore University Hospital
2015-2024
Northwell Health
2013-2024
Lenox Hill Hospital
2021
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2020
Rajiv Gandhi University of Health Sciences
2020
University of Nevada, Reno
2020
Hofstra University
2013-2018
Cardiovascular Research Foundation
2017
Victoria Heart Institute Foundation
2017
St. Francis Hospital
2016
•Patients with COVID-19 elevated troponin have markedly increased risk of death.•Patients were frequently admitted to intensive care units.•Risk is independent acute phase and inflammatory markers.•Risk baseline cardiovascular disease. Elevations in levels been shown predict mortality patients coronavirus disease 2019 (COVID-19). The role inflammation myocardial injury remains unclear. We sought determine the association a large, ethnically diverse population hospitalized COVID-19, markers...
Abstract Background The healthcare burden posed by the coronavirus disease 2019 (COVID‐19) pandemic in New York Metropolitan area has necessitated postponement of elective procedures resulting a marked reduction cardiac catheterization laboratory (CCL) volumes with potential to impact interventional cardiology (IC) fellowship training. Methods We conducted web‐based survey sent electronically 21 Accreditation Council for Graduate Medical Education accredited IC program directors (PDs) and...
The safety and efficacy of a novel cobalt alloy-based coronary stent with durable elastomeric polymer eluting the antiproliferative agent ridaforolimus for treatment patients artery disease is undetermined.
Because of the challenges in treating calcified coronary artery disease (CAD), lesion preparation has become increasingly important prior to percutaneous intervention (PCI). Despite growing data for both rotational atherectomy (RA) and orbital (OA), there have been no multicenter studies comparing safety efficacy both. We sought examine clinical outcomes patients with CAD who underwent atherectomy.A total 39 870 from five tertiary care hospitals had PCI January 2011 2017 were identified. 907...
BACKGROUND: Patients with an indication for oral anticoagulation who undergo percutaneous coronary intervention require a combination of and antiplatelet therapy. The use stent thromboresistant pro-healing coating may allow abbreviated duration dual therapy (DAPT) without increase in the risk thromboembolic events. METHODS: undergoing were randomized to treatment COBRA polyzene F (PzF) followed by 14 days DAPT or Food Drug Administration–approved new-generation drug-eluting 3 6 months DAPT....
Pulmonary embolisms (PEs) in coronavirus disease 2019 (COVID-19) have increasingly been reported observational studies. However, limited information describing their clinical characteristics and outcomes exists. Our study aims to describe features risk stratification strategies of hospitalized COVID-19 patients with PE. We retrospectively analyzed 101 infection acute Clinical measured were intensive care unit admission, mechanical ventilation, bleeding transfusion events, kidney injury (AKI)...
A coronary stent with thromboresistant and pro-healing properties such as the polymer polyzene F-coated (COBRA PzF) might safely allow for a very short duration of triple therapy in patients taking oral anticoagulation (OAC) who undergo stenting.The COBRA-REDUCE trial is prospective, multinational, randomized, open-label, assessor-blinded trial. total 996 at high bleeding risk because requirement OAC (with vitamin K antagonist or non-vitamin any indication) will be randomized sites United...
Background The acuity and magnitude of the first wave COVID‐19 epidemic in New York mandated a drastic change healthcare access delivery care. Methods Results We retrospectively studied patients admitted with an acute cardiovascular syndrome as their principal diagnosis to 13 hospitals across Northwell Health during March 11 through May 26, 2020 (first wave) same period 2019. Three thousand sixteen (242 positive) were for compared 9422 1 year prior (decrease 68.0%, P <0.001). During this...
Dextrocardia is a rare anomaly affecting 0.01% of newborns. We report on case 60‐year‐old female with mirror‐image dextrocardia who presented an acute myocardial infarction and underwent primary angioplasty the left circumflex artery. A review literature technical challenges will be addressed.
Abstract Objective The purpose of this study is to report on safety, short‐term and long‐term clinical efficacy following intracoronary brachytherapy (ICBT) for restenosis (ISR) in patients with drug eluting stents (DES). Background ICBT an effective treatment ISR bare metal (BMS) but its utilization has waned due the advent DES. DES occurs at a frequency 8% or greater. Method A retrospective analysis was performed treated institutional review board (IRB) approved protocol using between...
Hemodynamic support with Impella (Abiomed Inc., Danvers, MA) devices is becoming a more prevalent treatment option for patients cardiogenic shock (CS) undergoing percutaneous coronary intervention (PCI). There exists only limited published data regarding outcome differences between male and female patients. Therefore, the objective of this paper to analyze these gender short-term survival in-hospital outcomes in those PCI CS.Between January 2011 July 2016, simultaneous use were identified....
Background: The interventional treatment of complex high-risk indicated patients is technically difficult and can result in poor outcomes. Thus, percutaneous left ventricular assist devices are being increasingly used to provide hemodynamic support. No data available comparing male female for Complex High-risk Indicated Patients treated with devices. Our goal was evaluate in-hospital as well short term outcomes males females. Methods: There were 160 device use who not cardiogenic shock. A...